Phaos Technology Holdings (Cayman) (POAS) Payables (2024 - 2025)

Phaos Technology Holdings (Cayman)'s (POAS) quarterly Payables came in at $45018.3 in Q4 2025, down 35.94% on a QoQ basis from $70270.1 in Q2 2025.

Phaos Technology Holdings (Cayman) (POAS) Payables (2024 - 2025) Analysis & Trends

Phaos Technology Holdings (Cayman) (POAS) has 2 years of Payables data on file, last reported at $45018.3 in Q4 2025.

Quarterly Payables changed N/A year-over-year to $45018.3 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $45018.3 (changed N/A YoY) and the FY2025 annual result came in at $70334.4, down 67.77% from the prior year.
Payables slipped to $45018.3 in Q4 2025, from $70270.1 in the prior quarter.
In the past five years, Payables ranged from a high of $218221.5 in Q2 2024 to a low of $45018.3 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Payables (Qtr)
1	Abbott Laboratories	200.19 Bn	194.59 Bn	7.27 Bn	5.89 Bn
2	Stryker	129.95 Bn	126.47 Bn	4.50 Bn	2.00 Bn
3	Medtronic	120.06 Bn	110.84 Bn	6.41 Bn	2.64 Bn
4	Boston Scientific	74.14 Bn	73.60 Bn	3.85 Bn	1.23 Bn
5	Edwards Lifesciences	52.74 Bn	48.49 Bn	1.35 Bn	210.50 Mn
6	Dexcom	34.60 Bn	32.65 Bn	830.00 Mn	-
7	GE HealthCare Technologies	34.20 Bn	32.10 Bn	2.18 Bn	3.23 Bn
8	Koninklijke Philips	26.46 Bn	23.13 Bn	4.55 Bn	2.51 Bn
9	Steris	23.25 Bn	22.77 Bn	684.20 Mn	587.50 Mn
10	Phaos Technology Holdings (Cayman)	4.12 Mn	4.08 Mn	-	45,018.34

Download Data